Carlyle Group has agreed to divest its stake in HSO, a global Microsoft services partner, to Bain Capital. The deal price is $1 billion, according to sources close to the matter.

X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, ...

HeartFlow’s current products are HeartFlow Plaque analysis, which aims to provide clinicians with the ability to more ...

In The Bahamas, particularly in New Providence, the housing crisis remains rooted in soaring real estate prices and stagnant wages, but also in policy inertia, poor planning, and the compounding ...